The management of heart failure has evolved significantly over the years, but for some patients, conventional treatments are not enough. Heart failure and transplant cardiology focus on advanced therapeutic interventions, including the use of ventricular assist devices (VADs) and heart transplantation. When heart failure reaches an advanced stage, a transplant may be the only option for survival, but this requires careful evaluation of the patient’s overall health and compatibility with a donor heart. Post-transplant care is equally crucial, involving immunosuppressive drugs to prevent rejection, as well as ongoing monitoring for complications. Innovations in both transplant techniques and alternative therapies like gene therapy and stem cell treatments are paving the way for improved outcomes in these patients, offering hope for those with end-stage heart failure.
Title : Complete heart block and persistent left SVC: A pacing challenge after AV canal repair
Moataz Taha Mahmoud, Madinah Cardiac Center, Saudi Arabia
Title : Chemical detergent anionic surfactant-induced dry cardiomyopathy (Yasser’s cardiomyopathy) with parallel pupils/CXR phenomenon (Yasser’s ophthalmic phenomenon), up-down Yasser’s alternance, and an S1Q3-flat-T3 pattern-dramatic response to honey with possible cardiac regeneration- a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt
Title : Stabilization of molecular structures in red blood cell membrane by magnetite nanoparticles (ICNB) during storage
Andrey Belousov, Kharkiv National Medical University, Ukraine